Multidrug-resistant genes are associated with an 86-kb island in Acinetobacter baumannii

Trends in Microbiology

Volumn 14, Issue 9, 2006, Pages 375-378

  Roberts, Marilyn C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIMONY; ARSENIC; BETA LACTAM; CADMIUM; CHLORAMPHENICOL; COBALT; LEAD; MERCURY; QUATERNARY AMMONIUM DERIVATIVE; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; ZINC;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; COMPARATIVE STUDY; GENE; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; HOSPITAL INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; GENOME, BACTERIAL; METALS, HEAVY; MICROBIAL SENSITIVITY TESTS;

ACINETOBACTER BAUMANNII;

EID: 33747180202     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2006.07.005     Document Type: Short Survey

References (12)

1. Ferrara A.M. Potentially multidrug-resistant non-fermentative Gram-negative pathogens causing nosocomial pneumonia. Int. J. Antimicrob. Agents 27 (2006) 183-195
2. Holden M.T.G., et al. Complete genomes of two clinical Staphylococcus aureus: evidence for the rapid evolution of virulence and drug resistance. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 9786-9791
3. Fournier, P-E. et al. (2006) Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet. 2, e7, 62-72 (http://www.plosgenetics.org)
4. In: Craig N.L., et al. (Ed). Mobile DNA II (2002), ASM Press
5. Dijkshoorn L., et al. Prevalence of Acinetobacter baumannii and other Acinetobacter spp. in faecal samples from non-hospitalised individuals. Clin. Microbiol. Infect. 11 (2005) 329-332
6. Chang H.C., et al. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J. Clin. Microbiol. 43 (2005) 1632-1639
7. Joly-Guillou M.-L. Clinical impact and pathogenicity of Acinetobacter. Clin. Microbiol. Infect. 11 (2005) 868-873
8. Murray C.K., and Hospenthal D.R. Treatment of multidrug resistant Acinetobacter. Curr. Opin. Infect. Dis. 18 (2005) 502-506
9. Timurkaynak F., et al. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Int. J. Antimicrob. Agents 27 (2006) 224-228
10. Bergogne-Berezin E., and Towner K.J. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9 (1996) 148-165
11. Schmidt H., and Hensel M. Pathogenicity islands in bacterial pathogenesis. Clin. Microbiol. Rev. 17 (2004) 14-56
12. Cousin Jr. S., et al. Acquired macrolide resistance genes in pathogenic Neisseria spp. isolated between 1940 and 1987. Antimicrob. Agents Chemother. 47 (2003) 3877-3880